NCT03111485View on ClinicalTrials.gov

Effect of Long-acting Levodopa on Obstructive Sleep Apnea in Parkinson's Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

May 24, 2017

Primary Completion Date

October 28, 2022

Study Completion Date

October 28, 2022

Conditions
Parkinson's DiseaseObstructive Sleep Apnea
Interventions
DRUG

Sinemet CR

Capsule 250 mg / 50 mg taken at bedtime

DRUG

Placebo oral capsule

Capsule taken at bedtime

Trial Locations (1)

Unknown

McGill University Health Centre, Montreal

All Listed Sponsors
collaborator

Weston Brain Institute

OTHER

lead

McGill University Health Centre/Research Institute of the McGill University Health Centre

OTHER

NCT03111485 - Effect of Long-acting Levodopa on Obstructive Sleep Apnea in Parkinson's Disease | Biotech Hunter | Biotech Hunter